Coultreon Biopharma

Transforming lives with groundbreaking treatments

Biotechnology Research ยท Flemish Region

About

Coultreon Biopharma's mission (formerly Onco3R Therapeutics) is to develop life-changing medicines for patients affected by chronic inflammatory diseases of high unmet medical needs. The team is leveraging their knowledge and expertise to bring transformative innovations to patients suffering from auto-immune diseases. In this field, there is an urgent need for more convenient oral drugs that can offer greater efficacy with a better safety profile.

Details

  • Website: coultreon.com
  • Founded: 2025
  • Company Size: 30 employees
  • Headquarters: Heverlee, Flemish Region
  • Specialties: Drug Discovery, Drug Development, Immunology, Biotech, R&D